Edap Tms (NASDAQ:EDAP) was downgraded by stock analysts at TheStreet from a “c” rating to a “d+” rating in a research note issued on Tuesday.
A number of other equities research analysts have also commented on the company. HC Wainwright reiterated a “buy” rating and issued a $6.50 target price on shares of Edap Tms in a research report on Wednesday. Zacks Investment Research upgraded Edap Tms from a “sell” rating to a “hold” rating in a research report on Tuesday, April 10th. Finally, ValuEngine lowered Edap Tms from a “hold” rating to a “sell” rating in a research report on Wednesday, May 2nd.
Get Edap Tms alerts:
Shares of Edap Tms opened at $2.49 on Tuesday, according to MarketBeat Ratings. The company has a market capitalization of $70.46 million, a P/E ratio of -249.00 and a beta of 0.74. Edap Tms has a 52 week low of $2.43 and a 52 week high of $2.47. The company has a debt-to-equity ratio of 0.05, a quick ratio of 2.04 and a current ratio of 2.45.
Edap Tms (NASDAQ:EDAP) last issued its earnings results on Monday, May 14th. The medical equipment provider reported $0.03 EPS for the quarter, beating the Zacks’ consensus estimate of ($0.02) by $0.05. The firm had revenue of $11.28 million for the quarter, compared to analyst estimates of $10.46 million. Edap Tms had a negative return on equity of 5.89% and a negative net margin of 5.98%.
A hedge fund recently raised its stake in Edap Tms stock. Archon Capital Management LLC grew its stake in Edap Tms S.A. (NASDAQ:EDAP) by 7.5% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,019,011 shares of the medical equipment provider’s stock after purchasing an additional 71,336 shares during the period. Edap Tms comprises approximately 0.2% of Archon Capital Management LLC’s investment portfolio, making the stock its 14th largest holding. Archon Capital Management LLC owned 3.51% of Edap Tms worth $2,364,000 at the end of the most recent reporting period. 9.14% of the stock is owned by institutional investors and hedge funds.
About Edap Tms
EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally-invasive medical devices for the treatment of urological diseases worldwide. The company operates in two divisions: High Intensity Focused Ultrasound (HIFU), and Urology Devices and Services (UDS).